Prophylactic implantation of cardioverter-defibrillator in patients with severe cardiac amyloidosis and high risk for sudden cardiac death

Heart Rhythm

Volumn 5, Issue 2, 2008, Pages 235-240

  Kristen, Arnt V ^a   Dengler, Thomas J ^a   Hegenbart, Ute ^a   Schonland, Stefan O ^a   Goldschmidt, Hartmut ^a   Sack, Falk Udo ^a   Voss, Frederik ^a   Becker, Rüdiger ^a   Katus, Hugo A ^a   Bauer, Alexander ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Amyloid; Heart failure; Implantable cardioverter defibrillator; Sudden death; Survival

Indexed keywords

AMIODARONE; BRAIN NATRIURETIC PEPTIDE; DEXAMETHASONE; PROPAFENONE; TROPONIN T;

ADULT; AMINO TERMINAL SEQUENCE; ARTICLE; BRADYCARDIA; CLINICAL ARTICLE; CONTROLLED STUDY; DEFIBRILLATION; DEFIBRILLATOR; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOLLOW UP; GLIOBLASTOMA; HEART AMYLOIDOSIS; HEART TRANSPLANTATION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE PACING; HEART VENTRICLE TACHYCARDIA; HIGH RISK PATIENT; HUMAN; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SIDE EFFECT; SUDDEN DEATH; SURVIVOR; SYNCOPE; TREATMENT OUTCOME;

ADULT; AMYLOIDOSIS; CARDIOMYOPATHIES; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RESEARCH DESIGN; RISK ASSESSMENT; RISK FACTORS; VENTRICULAR FIBRILLATION;

EID: 38649104792     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2007.10.016     Document Type: Article

References (35)

1. Falk R.H., Comenzo R.L., and Skinner M. The systemic amyloidoses. N Engl J Med 337 (1997) 898-909
2. Obici L., Perfetti V., Palladini G., et al. Clinical aspects of systemic amyloid diseases. Biochim Biophys Acta 1753 (2005) 11-22
3. Perz J.B., Schonland S.O., Hundemer M., et al. High-dose melphalan with autologous stem cell transplantation after VAD induction chemotherapy for treatment of amyloid light chain amyloidosis: a single centre prospective phase II study. Br J Haematol 127 (2004) 543-551
4. Herlenius G., Wilczek H.E., Larsson M., et al. Ten years of international experience with liver transplantation for familial amyloidotic polyneuropathy: results from the Familial Amyloidotic Polyneuropathy World Transplant Registry. Transplantation 77 (2004) 64-71
5. Zenhausern R., Tobler A., Leoncini L., et al. Fatal cardiac arrhythmia after infusion of dimethyl sulfoxide-cryopreserved hematopoietic stem cells in a patient with severe primary cardiac amyloidosis and end-stage renal failure. Ann Hematol 79 (2000) 523-526
6. Wang M.M., and Pollard J.B. Postoperative ventricular fibrillation and undiagnosed primary amyloidosis. Anesthesiology 92 (2000) 871-872
7. Eriksson P., Boman K., Jacobsson B., et al. Cardiac arrhythmias in familial amyloid polyneuropathy during anaesthesia. Acta Anaesthesiol Scand 30 (1986) 317-320
8. Saba N., Sutton D., Ross H., et al. High treatment-related mortality in cardiac amyloid patients undergoing autologous stem cell transplant. Bone Marrow Transplant 24 (1999) 853-855
9. Dubrey S.W., Cha K., Anderson J., et al. The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement. Q J Med 91 (1998) 141-157
10. Dubrey S.W., Cha K., Skinner M., et al. Familial and primary (AL) cardiac amyloidosis: echocardiographically similar diseases with distinctly different clinical outcomes. Heart 78 (1997) 74-82
11. Palladini G., Malamani G., Co F., et al. Holter monitoring in AL amyloidosis: prognostic implications. Pacing Clin Electrophysiol 24 (2001) 1228-1233
12. Chamarthi B., Dubrey S.W., Cha K., et al. Features and prognosis of exertional syncope in light-chain associated AL cardiac amyloidosis. Am J Cardiol 80 (1997) 1242-1245
13. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. N Engl J Med 337 (1997) 1576-1583
14. Moss A.J., Hall W.J., Cannom D.S., et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 335 (1996) 1933-1940
15. Moss A.J., Zareba W., Hall W.J., et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 (2002) 877-883
16. Itoh M., Ohmori K., and Yata K. eee Implantable cardioverter defibrillator therapy in a patient with cardiac amyloidosis. Am J Hematol 81 (2006) 560-561
17. Wright B.L., Grace A.A., and Goodman H.J. Implantation of a cardioverter-defibrillator in a patient with cardiac amyloidosis. Nat Clin Pract Cardiovasc Med 3 (2006) 110-114
18. Reisinger J., Dubrey S.W., LaValley M., et al. Electrophysiologic abnormalities in AL (primary) amyloidosis with cardiac involvement. J Am Coll Cardiol 30 (1997) 1046-1051
19. Strege R.J., Saeger W., and Linke R.P. Diagnosis and immunohistochemical classification of systemic amyloidoses. Report of 43 cases in an unselected autopsy series. Virchows Arch 433 (1998) 19-27
20. Guidelines on the diagnosis and management of AL amyloidosis. Br J Haematol 125 (2004) 681-700 Anonymous
21. Palladini G., Campana C., Klersy C., et al. Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis. Circulation 107 (2003) 2440-2445
22. Yang C.W., Chun H.K., Oh Y.S., et al. Torsade de pointes and sudden death in a patient with amyloidosis-associated nephropathy. Nephron 70 (1995) 499
23. Hornsten R., Wiklund U., Suhr O.B., et al. Ventricular late potentials in familial amyloidotic polyneuropathy. J Electrocardiol 39 (2006) 57-62
24. Skadberg B.T., Bruserud O., Karwinski W., et al. Sudden death caused by heart block in a patient with multiple myeloma and cardiac amyloidosis. Acta Med Scand 223 (1988) 379-383
25. Hess E.P., and White R.D. Out-of-hospital cardiac arrest in patients with cardiac amyloidosis: presenting rhythms, management and outcomes in four patients. Resuscitation 60 (2004) 105-111
26. Ridolfi R.L., Bulkley B.H., and Hutchins G.M. The conduction system in cardiac amyloidosis. Clinical and pathologic features of 23 patients. Am J Med 62 (1977) 677-686
27. James T.N. Pathology of the cardiac conduction system in amyloidosis. Ann Intern Med 65 (1966) 28-36
28. Falk R.H., Rubinow A., and Cohen A.S. Cardiac arrhythmias in systemic amyloidosis: correlation with echocardiographic abnormalities. J Am Coll Cardiol 3 (1984) 107-113
29. Singh J.P., Hall W.J., McNitt S., et al. Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II). J Am Coll Cardiol 46 (2005) 1712-1720
30. Dispenzieri A., Kyle R.A., Gertz M.A., et al. Survival in patients with primary systemic amyloidosis and raised serum cardiac troponins. Lancet 361 (2003) 1787-1789
31. Kristen A.V., Perz J., Schonland S., et al. Non-invasive Predictors of Survival in Cardiac Amyloidosis. Eur J Heart Fail 9 (2007) 617-624
32. Zeier M., Perz J., Linke R.P., et al. No regression of renal AL amyloid in monoclonal gammopathy after successful autologous blood stem cell transplantation and significant clinical improvement. Nephrology 18 (2003) 2644-2647
33. Perz J.B., Kristen A.V., Rahemtulla A., et al. Long-term survival in a patient with AL amyloidosis after cardiac transplantation followed by autologous stem cell transplantation. Clin Res Cardiol 95 (2006) 1-4
34. Dubrey S.W., Burke M.M., Hawkins P.N., et al. Cardiac transplantation for amyloid heart disease: The United Kingdom experience. J Heart Lung Transplant 23 (2004) 1142-1153
35. Becker R., Haass M., Ick D., et al. Role of nonsustained ventricular tachycardia and programmed ventricular stimulation for risk stratification in patients with idiopathic dilated cardiomyopathy. Basic Res Cardiol 98 (2003) 259-266